Please wait

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)Registration Statements (Form S-1 Nos. 333-280919 and 333-284022) of Cidara Therapeutics, Inc., and

(2)Registration Statements (Form S-8 Nos. 333-203434, 333-210263, 333-216722, 333-228282, 333-231326, 333-236874, 333-253545, 333-259219, 333-263350, 333-270781, 333-278872 and 333-281523) pertaining to the Cidara Therapeutics, Inc. 2013 Stock Option and Grant Plan, Cidara Therapeutics, Inc. 2015 Equity Incentive Plan, Cidara Therapeutics, Inc. 2015 Employee Stock Purchase Plan, Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, as amended, and Cidara Therapeutics, Inc. 2024 Equity Incentive Plan;

of our report dated March 6, 2025, with respect to the consolidated financial statements of Cidara Therapeutics, Inc. included in this Annual Report (Form 10-K) of Cidara Therapeutics, Inc. for the year ended December 31, 2024.

/s/ Ernst & Young LLP

San Diego, California

March 6, 2025